TM-align: a protein structure alignment algorithm based on the TM-score
|
journal
|
April 2005 |
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
|
journal
|
November 2011 |
Broad and potent HIV-1 neutralization by a human antibody that binds the gp41–gp120 interface
|
journal
|
September 2014 |
Biochemical and Biological Characterization of a Dodecameric CD4-Ig Fusion Protein: IMPLICATIONS FOR THERAPEUTIC AND VACCINE STRATEGIES
|
journal
|
January 2002 |
Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients
|
journal
|
July 1985 |
Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody
|
journal
|
April 2013 |
Topological Analysis of HIV-1 Glycoproteins Expressed In Situ on Virus Surfaces Reveals Tighter Packing but Greater Conformational Flexibility than for Soluble gp120
|
journal
|
June 2013 |
Structure of a V3-Containing HIV-1 gp120 Core
|
journal
|
November 2005 |
Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
|
journal
|
June 1998 |
A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies
|
journal
|
September 2013 |
A Recombinant Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Complex Stabilized by an Intermolecular Disulfide Bond between the gp120 and gp41 Subunits Is an Antigenic Mimic of the Trimeric Virion-Associated Structure
|
journal
|
January 2000 |
Crystal structure of a human immunodeficiency virus type 1 neutralizing antibody, 50.1, in complex with its V3 loop peptide antigen.
|
journal
|
July 1993 |
Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody
|
journal
|
November 1994 |
HIV-1 Virus-Like Particles Bearing Pure Env Trimers Expose Neutralizing Epitopes but Occlude Nonneutralizing Epitopes
|
journal
|
February 2012 |
Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobility
|
journal
|
December 2009 |
Immunization with Recombinant Canarypox Vectors Expressing Membrane-Anchored Glycoprotein 120 Followed by Glycoprotein 160 Boosting Fails to Generate Antibodies That Neutralize R5 Primary Isolates of Human Immunodeficiency Virus Type 1
|
journal
|
December 2000 |
Core Structure of gp41 from the HIV Envelope Glycoprotein
|
journal
|
April 1997 |
The protein data bank: A computer-based archival file for macromolecular structures
|
journal
|
May 1977 |
Antibody potency relates to the ability to recognize the closed, pre-fusion form of HIV Env
|
journal
|
February 2015 |
Stable, uncleaved HIV-1 envelope glycoprotein gp140 forms a tightly folded trimer with a native-like structure
|
journal
|
December 2014 |
Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1
|
journal
|
July 2014 |
Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
|
journal
|
July 2010 |
Neutralization Escape Variants of Human Immunodeficiency Virus Type 1 Are Transmitted from Mother to Infant
|
journal
|
December 2005 |
Structural Mechanism of Trimeric HIV-1 Envelope Glycoprotein Activation
|
journal
|
July 2012 |
EMAN2: An extensible image processing suite for electron microscopy
|
journal
|
January 2007 |
Conformational dynamics of single HIV-1 envelope trimers on the surface of native virions
|
journal
|
October 2014 |
Antibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition
|
journal
|
June 2003 |
Structural Rationale for the Broad Neutralization of HIV-1 by Human Monoclonal Antibody 447-52D
|
journal
|
February 2004 |
Molecular architecture of native HIV-1 gp120 trimers
|
journal
|
July 2008 |
Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers
|
journal
|
May 2011 |
Unliganded HIV-1 gp120 core structures assume the CD4-bound conformation with regulation by quaternary interactions and variable loops
|
journal
|
March 2012 |
Antibody neutralization and escape by HIV-1
|
journal
|
March 2003 |
A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
|
journal
|
October 2011 |
Structure of Respiratory Syncytial Virus Fusion Glycoprotein in the Postfusion Conformation Reveals Preservation of Neutralizing Epitopes
|
journal
|
May 2011 |
Highly Conserved Protective Epitopes on Influenza B Viruses
|
journal
|
August 2012 |
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies
|
journal
|
March 2014 |
Well-Ordered Trimeric HIV-1 Subtype B and C Soluble Spike Mimetics Generated by Negative Selection Display Native-like Properties
|
journal
|
January 2015 |
Thermodynamic Signatures of the Antigen Binding Site of mAb 447–52D Targeting the Third Variable Region of HIV-1 gp120
|
journal
|
August 2013 |
[20] Processing of X-ray diffraction data collected in oscillation mode
|
book
|
January 1997 |
HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites
|
journal
|
December 2002 |
Structure and immune recognition of trimeric pre-fusion HIV-1 Env
|
journal
|
October 2014 |
Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS
|
journal
|
June 1986 |
The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens
|
journal
|
June 1998 |
Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120
|
journal
|
February 2004 |
Atomic structure of the ectodomain from HIV-1 gp41
|
journal
|
May 1997 |
Antibody 8ANC195 Reveals a Site of Broad Vulnerability on the HIV-1 Envelope Spike
|
journal
|
May 2014 |
Broad neutralization coverage of HIV by multiple highly potent antibodies
|
journal
|
September 2011 |
Delineating Antibody Recognition in Polyclonal Sera from Patterns of HIV-1 Isolate Neutralization
|
journal
|
May 2013 |
Human Anti-V3 HIV-1 Monoclonal Antibodies Encoded by the VH5-51/VL Lambda Genes Define a Conserved Antigenic Structure
|
journal
|
December 2011 |
Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
|
journal
|
October 2013 |
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals
|
journal
|
March 2009 |
Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer
|
journal
|
October 2013 |
Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer
|
journal
|
October 2013 |
Recent developments in the PHENIX software for automated crystallographic structure determination
|
journal
|
November 2003 |
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
|
journal
|
July 2010 |
Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies
|
journal
|
November 2009 |
Sparse matrix sampling: a screening method for crystallization of proteins
|
journal
|
August 1991 |
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
|
journal
|
April 2013 |
Reduced surface: An efficient way to compute molecular surfaces
|
journal
|
March 1996 |
Relative resistance of primary HIV-1 isolates to neutralization by soluble CD4
|
journal
|
April 1991 |
HIV-1 neutralizing antibodies induced by native-like envelope trimers
|
journal
|
June 2015 |
The Cross-Clade Neutralizing Activity of a Human Monoclonal Antibody Is Determined by the GPGR V3 Motif of HIV Type 1
|
journal
|
November 2004 |
Epitope mapping and characterization of a novel CD4-induced human monoclonal antibody capable of neutralizing primary HIV-1 strains
|
journal
|
October 2003 |
Emergence of Resistant Human Immunodeficiency Virus Type 1 in Patients Receiving Fusion Inhibitor (T-20) Monotherapy
|
journal
|
June 2002 |
Enzyme Digests Eliminate Nonfunctional Env from HIV-1 Particle Surfaces, Leaving Native Env Trimers Intact and Viral Infectivity Unaffected
|
journal
|
April 2011 |
CD4-Induced Activation in a Soluble HIV-1 Env Trimer
|
journal
|
July 2014 |
Efficient protein boosting after plasmid DNA or recombinant adenovirus immunization with HIV-1 vaccine constructs
|
journal
|
February 2007 |
Enhancing Protein Crystallization through Precipitant Synergy
|
journal
|
September 2003 |
Broadly Neutralizing Influenza Hemagglutinin Stem-Specific Antibody CR8020 Targets Residues that Are Prone to Escape due to Host Selection Pressure
|
journal
|
May 2014 |
Conserved structural elements in the V3 crown of HIV-1 gp120
|
journal
|
July 2010 |
Prefusion structure of trimeric HIV-1 envelope glycoprotein determined by cryo-electron microscopy
|
journal
|
October 2013 |
Automated electron microscope tomography using robust prediction of specimen movements
|
journal
|
October 2005 |
Structural definition of a conserved neutralization epitope on HIV-1 gp120
|
journal
|
February 2007 |
Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons
|
journal
|
December 1991 |
Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120
|
journal
|
November 2009 |
Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex.
|
journal
|
January 1997 |
Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1.
|
journal
|
January 1996 |
Reduced surface: An efficient way to compute molecular surfaces
|
journal
|
March 1996 |
Preclinical Development of a Fusion Peptide Conjugate as an HIV Vaccine Immunogen
|
journal
|
February 2020 |
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
|
text
|
January 2013 |
Placebo-Controlled Phase 3 Trial Of A Recombinant Glycoprotein 120 Vaccine To Prevent Hiv-1 Infection
|
text
|
January 2005 |
Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS
|
text
|
January 1986 |
The protein data bank: A computer-based archival file for macromolecular structures
|
journal
|
January 1978 |
Neutralization Escape Variants of Human Immunodeficiency Virus Type 1 Are Transmitted from Mother to Infant
|
journal
|
March 2006 |
Structure and immune recognition of trimeric pre-fusion HIV-1 Env
|
text
|
January 2014 |
Placebo-Controlled Phase 3 Trial of a Recombinant Glycoprotein 120 Vaccine to Prevent HIV-1 Infection
|
journalarticle
|
January 2005 |
A stamp on the envelope
|
journal
|
October 2014 |
Coot model-building tools for molecular graphics
|
journal
|
November 2004 |
Crystal Structures of Human Immunodeficiency Virus Type 1 (HIV-1) Neutralizing Antibody 2219 in Complex with Three Different V3 Peptides Reveal a New Binding Mode for HIV-1 Cross-Reactivity
|
journal
|
May 2006 |
Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding.
|
journal
|
January 1993 |
Effect of Soluble CD4 on Exposure of Epitopes on Primary, Intact, Native Human Immunodeficiency Virus Type 1 Virions of Different Genetic Clades
|
journal
|
August 2001 |
Soluble Mimetics of Human Immunodeficiency Virus Type 1 Viral Spikes Produced by Replacement of the Native Trimerization Domain with a Heterologous Trimerization Motif: Characterization and Ligand Binding Analysis
|
journal
|
July 2005 |
HIV-1 rational vaccine design: molecular details of b12–gp120 complex structure
|
journal
|
June 2007 |